Direct monitoring of albumin lysine-525 N-homocysteinylation in human serum by liquid chromatography/mass spectrometry

Analytical Biochemistry

Volumn 405, Issue 1, 2010, Pages 132-134

  Sikora, Marta ^a   Marczak, Łukasz ^a   Twardowski, Tomasz ^a   Stobiecki, Maciej ^a   Jakubowski, Hieronim ^a,b  

^a POLISH ACADEMY OF SCIENCES   (Poland)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Albumin lysine N homocysteinylation; Cystathionine synthase deficiency; Homocysteine thiolactone; LC MS; Site specific modification

Indexed keywords

AMINO ACIDS; NEURODEGENERATIVE DISEASES; PROTEINS; SPECTROMETRY;

ALBUMIN LYSINE N-HOMOCYSTEINYLATION; HOMOCYSTEINES; LC/MS; SITE-SPECIFIC MODIFICATIONS; SYNTHASES;

LIQUID CHROMATOGRAPHY;

ALBUMIN; CYSTATHIONINE BETA SYNTHASE; HOMOCYSTEINE THIOLACTONE; LYSINE; HOMOCYSTEINE; SERUM ALBUMIN;

ARTICLE; BLOOD SAMPLING; CATALYSIS; ENZYME DEFICIENCY; HUMAN; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROCESSING; AMINO ACID SEQUENCE; BLOOD; DEFICIENCY; GENETICS; METABOLISM; PROCEDURES;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, LIQUID; CYSTATHIONINE BETA-SYNTHASE; HOMOCYSTEINE; HUMANS; LYSINE; MASS SPECTROMETRY; PROTEIN PROCESSING, POST-TRANSLATIONAL; SERUM ALBUMIN;

EID: 77955094846     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.04.034     Document Type: Article

References (20)

1. Lentz S.R. Mechanisms of homocysteine-induced atherothrombosis. J. Thromb. Haemost. 2005, 3:1646-1654.
2. Jakubowski H. The molecular basis of homocysteine thiolactone-mediated vascular disease. Clin. Chem. Lab. Med. 2007, 45:1704-1716.
3. Jakubowski H. Metabolism of homocysteine thiolactone in human cell cultures: possible mechanism for pathological consequences of elevated homocysteine levels. J. Biol. Chem. 1997, 272:1935-1942.
4. Chwatko G., Boers G.H., Strauss K.A., Shih D.M., Jakubowski H. Mutations in methylenetetrahydrofolate reductase or cystathionine β-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice. FASEB J. 2007, 21:1707-1713.
5. Jakubowski H. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J. 1999, 13:2277-2283.
6. Glowacki R., Jakubowski H. Cross-talk between Cys34 and lysine residues in human serum albumin revealed by N-homocysteinylation. J. Biol. Chem. 2004, 279:10864-10871.
7. Jakubowski H. Molecular basis of homocysteine toxicity in humans. Cell. Mol. Life Sci. 2004, 61:470-487.
8. Perla-Kajan J., Marczak L., Kajan L., Skowronek P., Twardowski T., Jakubowski H. Modification by homocysteine thiolactone affects redox status of cytochrome c. Biochemistry 2007, 46:6225-6231.
9. Sibrian-Vazquez M., Escobedo J.O., Lim S., Samoei G.K., Strongin R.M. Homocystamides promote free-radical and oxidative damage to proteins. Proc. Natl. Acad. Sci. USA 2010, 107:551-554.
10. Undas A., Perla J., Lacinski M., Trzeciak W., Kazmierski R., Jakubowski H. Autoantibodies against N-homocysteinylated proteins in humans: implications for atherosclerosis. Stroke 2004, 35:1299-1304.
11. Undas A., Stepien E., Glowacki R., Tisonczyk J., Tracz W., Jakubowski H. Folic acid administration and antibodies against homocysteinylated proteins in subjects with hyperhomocysteinemia. Thromb. Haemost. 2006, 96:342-347.
12. Sauls D.L., Lockhart E., Warren M.E., Lenkowski A., Wilhelm S.E., Hoffman M. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia. Biochemistry 2006, 45:2480-2487.
13. Jakubowski H., Boers G.H., Strauss K.A. Mutations in cystathionine β-synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans. FASEB J. 2008, 22:4071-4076.
14. Yang X., Gao Y., Zhou J., Zhen Y., Yang Y., Wang J., Song L., Liu Y., Xu H., Chen Z., Hui R. Plasma homocysteine thiolactone adducts associated with risk of coronary heart disease. Clin. Chim. Acta 2006, 364:230-234.
15. Gu W., Lu J., Yang G., Dou J., Mu Y., Meng J., Pan C. Plasma homocysteine thiolactone associated with risk of macrovasculopathy in Chinese patients with type 2 diabetes mellitus. Adv. Ther. 2008, 25:914-924.
16. Jakubowski H. Homocysteine is a protein amino acid in humans: implications for homocysteine-linked disease. J. Biol. Chem. 2002, 277:30425-30428.
17. Jakubowski H. New method for the determination of protein N-linked homocysteine. Anal. Biochem. 2008, 380:257-261.
18. Perla-Kajan J., Stanger O., Luczak M., Ziolkowska A., Malendowicz L.K., Twardowski T., Lhotak S., Austin R.C., Jakubowski H. Immunohistochemical detection of N-homocysteinylated proteins in humans and mice. Biomed. Pharmacother. 2008, 62:473-479.
19. Zang T., Dai S., Chen D., Lee B.W., Liu S., Karger B.L., Zhou Z.S. Chemical methods for the detection of protein N-homocysteinylation via selective reactions with aldehydes. Anal. Chem. 2009, 81:9065-9071.
20. Lacinski M., Skorupski W., Cieslinski A., Sokolowska J., Trzeciak W.H., Jakubowski H. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans. Cell. Mol. Biol. (Noisy-le-grand) 2004, 50:885-893.